Thursday, May 28, 2026
Home Authors Posts by Ogkologos

Ogkologos

4236 POSTS 0 COMMENTS

OS Advantage of Gotistobart Over Docetaxel in Patients with anti-PD‑(L)1- and...

Ogkologos -
0

Safety and Antitumour Activity of Setidegrasib in Patients with Previously Treated...

Ogkologos -
0

EMA Recommends Granting a Marketing Authorisation for Poherdy

Ogkologos -
0

Whole-Genome Sequencing Meets Diagnostic Requirements in Routine Practice for Patients with...

Ogkologos -
0

FDA Approves Relacorilant with nab-Paclitaxel for Platinum-Resistant Epithelial Ovarian, Fallopian Tube,...

Ogkologos -
0

Efficacy of Pembrolizumab and Olaparib Combination Observed in a Subset of Patients with HRD Metastatic Pancreatic Cancer  

Ogkologos -
0

Nomination Process for the 2026 ESMO Society Awards Now Open

Ogkologos -
0

EMA Recommends Extension of Therapeutic Indications for Asciminib

Ogkologos -
0

NHS England Lung Cancer Screening Programme Demonstrates that it is Feasible and Scalable...

Ogkologos -
0

ESMO Welcomes European Parliament (EP) Draft Report on Psychosocial Risks at...

Ogkologos -
0
1...456...424Page 5 of 424

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com